Sandip Kapadia
CIK: 0001677141
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- May 19, 2026PASG
Passage BIO, Inc.
Award(A)DirectDirector Stock Option (right to buy)
10.5K shares- - Jan 26, 2026HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct3.7K shares at avg. $37.15$139K - Jan 25, 2026HRMY
Harmony Biosciences Holdings, Inc.
Tax Payment(F)Direct2.6K shares at avg. $36.82$94K - Jan 25, 2026HRMY
Harmony Biosciences Holdings, Inc.
Exercise(M)Direct4.7K shares- - Jan 24, 2026HRMY
Harmony Biosciences Holdings, Inc.
Tax Payment(F)Direct2.2K shares at avg. $36.82$82K - Jan 24, 2026HRMY
Harmony Biosciences Holdings, Inc.
Exercise(M)Direct3.8K shares- - Jan 22, 2026HRMY
Harmony Biosciences Holdings, Inc.
Award(A)DirectRestricted Stock Units
12.2K shares- - Jan 22, 2026HRMY
Harmony Biosciences Holdings, Inc.
Award(A)DirectStock Option
42.6K shares- - Jan 15, 2026HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct21K shares at avg. $35.92$753K - Dec 5, 2025HRMY
Harmony Biosciences Holdings, Inc.
Exercise(M)Direct20K shares at avg. $29.03$581K - Dec 5, 2025HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct20K shares at avg. $39.54$791K - Nov 21, 2025HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct3.4K shares at avg. $35.00$120K - Sep 30, 2025HRMY
Harmony Biosciences Holdings, Inc.
Exercise(M)Direct45K shares- - Sep 30, 2025HRMY
Harmony Biosciences Holdings, Inc.
Tax Payment(F)Direct24K shares at avg. $27.56$663K - Aug 15, 2025HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct21.6K shares at avg. $36.50$787K - May 28, 2025PASG
Passage BIO, Inc.
Award(A)DirectDirector Stock Option (right to buy)
201.9K shares- - Apr 1, 2025HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct6.2K shares at avg. $32.48$203K - Apr 1, 2025HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct740 shares at avg. $33.12$25K - Mar 29, 2025HRMY
Harmony Biosciences Holdings, Inc.
Tax Payment(F)Direct8K shares at avg. $33.19$266K - Mar 29, 2025HRMY
Harmony Biosciences Holdings, Inc.
Exercise(M)Direct15K shares- - Jan 27, 2025HRMY
Harmony Biosciences Holdings, Inc.
Sale(S)Direct1.8K shares at avg. $38.05$68K - Jan 25, 2025HRMY
Harmony Biosciences Holdings, Inc.
Award(A)DirectStock Option
66.3K shares- - Jan 25, 2025HRMY
Harmony Biosciences Holdings, Inc.
Award(A)DirectRestricted Stock Units
18.9K shares- - Jan 24, 2025HRMY
Harmony Biosciences Holdings, Inc.
Exercise(M)Direct3.8K shares- - Jan 24, 2025HRMY
Harmony Biosciences Holdings, Inc.
Tax Payment(F)Direct2K shares at avg. $38.01$77K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 | PASG Passage BIO, Inc. | Award(A) Director Stock Option (right to buy) | 10,539 | - | - | Direct |
| Jan 26, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 3,746 | $37.15 | $139,171 | Direct |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Tax Payment(F) | 2,553 | $36.82 | $94,001 | Direct |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Exercise(M) | 4,725 | - | $0 | Direct |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Tax Payment(F) | 2,239 | $36.82 | $82,440 | Direct |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Exercise(M) | 3,813 | - | $0 | Direct |
| Jan 22, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Award(A) Restricted Stock Units | 12,200 | - | - | Direct |
| Jan 22, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Award(A) Stock Option | 42,600 | - | - | Direct |
| Jan 15, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 20,961 | $35.92 | $752,833 | Direct |
| Dec 5, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Exercise(M) | 20,000 | $29.03 | $580,600 | Direct |
| Dec 5, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 20,000 | $39.54 | $790,896 | Direct |
| Nov 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 3,427 | $35.00 | $119,945 | Direct |
| Sep 30, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Exercise(M) | 45,000 | - | - | Direct |
| Sep 30, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Tax Payment(F) | 24,039 | $27.56 | $662,515 | Direct |
| Aug 15, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 21,573 | $36.50 | $787,378 | Direct |
| May 28, 2025 | PASG Passage BIO, Inc. | Award(A) Director Stock Option (right to buy) | 201,857 | - | - | Direct |
| Apr 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 6,247 | $32.48 | $202,881 | Direct |
| Apr 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 740 | $33.12 | $24,505 | Direct |
| Mar 29, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Tax Payment(F) | 8,014 | $33.19 | $265,985 | Direct |
| Mar 29, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Exercise(M) | 15,000 | - | - | Direct |
| Jan 27, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Sale(S) | 1,775 | $38.05 | $67,547 | Direct |
| Jan 25, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Award(A) Stock Option | 66,250 | - | - | Direct |
| Jan 25, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Award(A) Restricted Stock Units | 18,900 | - | - | Direct |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Exercise(M) | 3,812 | - | $0 | Direct |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Tax Payment(F) | 2,037 | $38.01 | $77,426 | Direct |
1-25 of 29 transactions
About Kapadia Sandip
Kapadia Sandip (SEC CIK 0001677141) files insider reports with the SEC as Director of Passage BIO, Inc. (PASG) and CHIEF FINANCIAL OFFICER of Harmony Biosciences Holdings, Inc. (HRMY).
Signal8 holds 14 ownership filings by Kapadia Sandip, all Form 4s, filed between Oct 2, 2024 and May 21, 2026. Those filings report 29 transactions, from Sep 30, 2024 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kapadia Sandip's filings is in PLYMOUTH MEETING, PA.
Recent filings by Kapadia Sandip
- May 19, 2026: Grant or award of PASG derivative securities (Form 4, code A).
- Jan 26, 2026: Open-market sale of HRMY shares (Form 4, code S).
- Jan 25, 2026: Tax withholding of HRMY shares (Form 4, code F).
- Jan 25, 2026: Option exercise of HRMY shares (Form 4, code M).
- Jan 24, 2026: Tax withholding of HRMY shares (Form 4, code F).
Other insiders filing for Passage BIO, Inc. (PASG)
- Lynx1 Capital Management LP, 10% Owner
- Sondhi Dolan, Director
- Porter Derrell, Director
- Kassberg Thomas Richard, Director
- GOWEN MAXINE, Director
- Countouriotis Athena, Director